Delivery Order SPE2DB24D3013-SPE2DB25FFLVL
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of LIALDA DR 1.2 GM TABLET 120S. The contract has a firm fixed price of $3,236.85 and a period of performance through March 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award, valued at $1,573.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type and is set to expire on June 25, 2024. The award is for the supply of 4564987076 - LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will deliver...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,714.39 firm fixed-price delivery order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.09 delivery order contract is for the supply of Lialda DR 1.2 GM Tablets, a specialty medication. The contract has a completion date of September 7, 2021 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,150 units of the prescription drug Lialda (mesalamine) in 120-count tablet bottles. The $2,807.73 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
This federal contract award is for the delivery of 4554358172 LIALDA DR 1.2 GM TABLET 120S to the Defense Logistics Agency (DLA). The contract, valued at $3,773.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 9, 2021 with an ultimate completion date of August 10, 2021. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply LIALDA DR 1.2 GM tablets. The order, valued at $2,444.37, requires delivery of 120 tablets to a facility located in Conshohocken, Pennsylvania by November 21, 2023. No set aside designation was applied to this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to various...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,696.67 contract is for the supply of 120 tablets of the drug Lialda (mesalamine 1.2 gram) to support military and federal healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as...
This federal contract award, with ID SPE2DB20D3505|SPE2DB21FU3Y7, was issued by the Defense Logistics Agency (DLA) and awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,349.66 Firm Fixed Price delivery order is for the pharmaceutical product LIALDA DR 1.2 GM TABLET 120S. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,420.36 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR, to be delivered from its Conshohocken, Pennsylvania facility by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing medical supplies to support the...